Document type
ArticleVersion
Accepted versionPublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/124909
Toward angiogenesis inhibitors based on the conjugation of organometallic platinum(II) complexes to RGD peptides
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
A novel conjugate between a cyclometalated platinum(II) complex with dual antiangiogenic and antitumor activity and a cyclic peptide containing the RGD sequence (-Arg-Gly-Asp-) has been synthesized by combining solid- and solution-phase methodologies. Although peptide conjugation rendered a non-cytotoxic compound in all tested tumor cell lines (± αV β3 and αV β5 integrin receptors), the antiangiogenic activity of the Pt-c(RGDfK) conjugate in human umbilical vein endothelial cells at sub-cytotoxic concentrations opens the way to the design of a novel class of angiogenesis inhibitors through conjugation of metallodrugs with high antiangiogenic activity to cyclic RGD-containing peptides or peptidomimetic analogues.
Subject
Subject (English)
Citation
Citation
ZAMORA, Ana, et al. Toward angiogenesis inhibitors based on the conjugation of organometallic platinum(II) complexes to RGD peptides. ChemMedChem. 2018. Vol. 13, num. 17, pags. 1755-1762. ISSN 1860-7179. [consulted: 16 of June of 2026]. Available at: https://hdl.handle.net/2445/124909